ArticleFrontiers in cardiovascular medicine2022

Shexiang Baoxin Pill (MUSKARDIA) reduces major adverse cardiovascular events in women with stable coronary artery disease: A subgroup analysis of a phase IV randomized clinical trial.

Haiming Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.